Discharged on supplemental oxygen from an emergency department in patients with bronchiolitis

Pediatrics
Sarah HalsteadLalit Bajaj

Abstract

Bronchiolitis is the most common reason for hospital admission in patients aged <1 year. Admissions have been increasing with hypoxia frequently cited as the determinant. Home oxygen (O(2)) has been shown to be feasible, although safety data are lacking. The objective of this study was to evaluate the impact of a home O(2) clinical care protocol on admission rates in patients with bronchiolitis from the pediatric emergency department. We performed a retrospective chart review of patients with bronchiolitis who presented to a children's hospital pediatric emergency department (altitude 1600 m) between 2005 and 2009. Patients between the ages of 1 and 18 months were included in the analysis. Patients requiring baseline O(2) were excluded. We calculated the percentage of patients discharged on O(2) and their readmission rates. We reviewed charts of patients who were admitted after home O(2) for adverse outcomes. We also compared rates of admission before and after initiation of the protocol. In this study, 4194 illnesses were analyzed; 2383 (57%) were discharged on room air, 649 (15%) were discharged on O(2), and 1162 (28%) were admitted. Of those discharged on room air, 4% were subsequently admitted, and 6% of those discharged on...Continue Reading

References

May 14, 1998·European Journal of Pediatrics·M C KneyberH A Moll
Oct 27, 1999·JAMA : the Journal of the American Medical Association·D K ShayL J Anderson
Oct 5, 2001·Clinical Pediatrics·A M HarrisonR K Kanter
Jun 18, 2002·Chest·Uma R KotagalMark S Kirschbaum
Nov 15, 2003·The Journal of Pediatrics·Shelah Leader, Kimmie Kohlhase
Nov 26, 2003·The Journal of Infectious Diseases·Joanne M LangleyElaine E L Wang
Dec 5, 2003·Pediatrics·Alan R SchroederThomas B Newman
Jun 9, 2004·Archives of Pediatrics & Adolescent Medicine·Alan R SchroederThomas B Newman
Apr 5, 2005·Pediatrics·Dimitri A ChristakisDanielle M Zerr
Sep 26, 2006·Annals of Emergency Medicine·Ben M WillwerthDavid S Greenes
Oct 4, 2006·Pediatrics·UNKNOWN American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis
Dec 5, 2006·Pediatrics·Andrea J PelletierCarlos A Camargo
Jul 27, 2007·The New England Journal of Medicine·Howard M CorneliUNKNOWN Bronchiolitis Study Group of the Pediatric Emergency Care Applied Research Network (PECARN)
Oct 18, 2008·Archives of Disease in Childhood·S W TieA C Martin
Jan 27, 2010·Pediatrics·Joseph J Zorc, Caroline Breese Hall
Nov 23, 2010·Pediatric Emergency Care·David R SandweissHoward A Kadish

❮ Previous
Next ❯

Citations

Apr 18, 2014·Current Opinion in Pediatrics·Alan R Schroeder, Jonathan M Mansbach
Oct 12, 2012·European Journal of Pediatrics·Kris De Boeck
Sep 28, 2012·European Journal of Pediatrics·Marie GauthierIsabelle Chevalier
Aug 26, 2014·Clinical Pediatrics·Julia Fuzak FreemanDavid Sandweiss
Feb 17, 2017·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Julia Fuzak FreemanLalit Bajaj
Aug 17, 2018·JBI Database of Systematic Reviews and Implementation Reports·Terra Watkins, Shelia Keller
Aug 13, 2013·The Pediatric Infectious Disease Journal·Kohei HasegawaCarlos A Camargo
Feb 2, 2021·BMC Infectious Diseases·Jiahong TanXuejun Shao
May 1, 2021·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Timothy J D OhlsenEric R Coon
Oct 29, 2014·Pediatrics·Shawn L RalstonSinsi Hernandez-Cancio
Dec 31, 2021·Journal of Paediatrics and Child Health·Isabel M Cabrera LópezRaquel Jiménez García

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Disease in Childhood
Prasad Nagakumar, Iolo Doull
The Pediatric Infectious Disease Journal
Xavier Carbonell-EstranyPediatric Investigators Collaborative Network on Infections in Canada Study Group
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
D Dimova-YanevaP J Helms
Archives of Pediatrics & Adolescent Medicine
G H SwinglerM Zwarenstein
© 2022 Meta ULC. All rights reserved